The Improtance of Human Breast Development in Mammary Carcinogenesis
  • Barry A. Gusterson
  • Micahel Stratton
  • Ramaswamy Anbazhagan
Conference paper


Breast cancer is a heterogeneous disease, in terms of both its clinical course and its underlying molecular abnormalities. Its etiology is likely to involve a combination of congenital and acquired abnormalities. The introduction of this section focuses on the significance of human breast development and its possible contribution to our understanding of the roles of hormones and other factors in mammary carcinogenesis. The accompanying chapters will deal with the use of breast cancer animal model systems and their susceptibility to carcinogens, the definition of early events in mammary carcinogenesis, and the pathogenesis of the disease in relation to hormones and growth factors.


Breast Cancer Male Breast Cancer Androgen Receptor Gene Breast Development Mammary Carcinogenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tomatis L (1979) Prenatal exposure to chemical carcinogens and its effect on subsequent generations. Natl Cancer Inst Monog 51:159–184.Google Scholar
  2. 2.
    Greenwald P, Barlow JJ, Nasca PC, Burnett WS (1971) Virginal cancer after maternal treatment with synthetic estrogens. N Engl J Med 285:390–392.PubMedCrossRefGoogle Scholar
  3. 3.
    Kato H, Yoshimoto Y, Schull WJ (1986) Risk of cancer among children exposed to atomic bomb radiation in utero: A review. In Napalkov NP, Rice JM, Tomatis L, Yamasaki H (eds): Perinatal and Multigeneration Carcinogenesis. IARC Scientific Publications No. 96. Lyon International Agency for Research on Cancer, pp 365–374.Google Scholar
  4. 4.
    Anbazhagen R, Gusterson BA (1994) Prenatal factors may influence predisposition to breast cancer. Eur J Cancer 30A (l): l–3.Google Scholar
  5. 5.
    Millar WR (1993) Breast cancer. Hormonal factors and risk of breast cancer. Lancet 341:25–26.CrossRefGoogle Scholar
  6. 6.
    Hall JM, Lee MK, Morrow J, et al. (1990) Linkage of early onset familial breast cancer to chromosome 17q21. Science 250:1684–1689.PubMedCrossRefGoogle Scholar
  7. 7.
    Easton DF, Bishop DT, Ford D, et al. (1993) Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678–701.PubMedGoogle Scholar
  8. 8.
    Wooster R, Mangion J, Eeles R, et al. (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2:132–134.PubMedCrossRefGoogle Scholar
  9. 9.
    Lobaccaro J-M, Lumbroso S, Belon C, et al. (1993) Male breast cancer and the androgen receptor gene. Nature Genet 5:109–110.PubMedCrossRefGoogle Scholar
  10. 10.
    Stratton MR, Ford D, Neuhausen S, et al. (1994) Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nature Genet 7:103–107.PubMedCrossRefGoogle Scholar
  11. 11.
    Nathan B, Anbazhagan R, Clarkson P, et al. (1994) Expression of BCL2 in the developing human fetal and infant breast. Histopath 24:73–76.CrossRefGoogle Scholar
  12. 12.
    Otsuki Y, Misaki O, Sugimoto O, et al. (1994) Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 344:28–29.PubMedCrossRefGoogle Scholar
  13. 13.
    Nathan B, Gusterson B, Jadayel D, et al. (1994) Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. Ann Oncol 5:409–414.PubMedGoogle Scholar
  14. 14.
    Atherton AJ, Anbazhagan R, Monaghan P, et al. (1994) Immunolocalisation of cell surface peptidases in the developing human breast. Differentiation 56:101–106.PubMedGoogle Scholar
  15. 15.
    Atherton AJ, Monaghan P, Warburton MJ, et al. (1992) Dipeptidyl peptidase IV expression identifies a functional subpopulation of breast fibroblasts. Int J Cancer 50:15–19.PubMedCrossRefGoogle Scholar
  16. 16.
    Kenny AJ, O’Hare MJ, Gusterson BA (1989) Cell surface peptidases as modulators of growth and differentiation. Lancet 785–787.Google Scholar
  17. 17.
    Gusterson BA, Monaghan P, Mahendran R, et al. (1986) Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukaemia antigen antibody A12. J Natl Cancer Inst 77:343–349.PubMedGoogle Scholar
  18. 18.
    Butta A, MacLennan K, Flanders KC, et al. (1992) Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res 52:4261–4264.PubMedGoogle Scholar
  19. 19.
    Dickson RB, Lippman ME (1988) Control of human breast cancer by estrogen, growth factors and oncogenes. In Dickson RB, Lippman ME (eds): Breast Cancer: Cellular and Molecular Biology. Boston: Kluwer Academic Publishers, pp 119–165.Google Scholar
  20. 20.
    Ramachandra S, Machin L, Ashley S, et al. (1990) Immunohistochemical distribution of c-erb B-2 in in situ breast carcinoma—A detailed morphological analysis. J Pathol 161:7–14.PubMedCrossRefGoogle Scholar
  21. 21.
    Gusterson BA, Shipley J, Crew J (1994) Applications of molecular genetics and cytogenetics to breast cancer and soft tissue sarcomas. Annals Oncol, in press.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • Barry A. Gusterson
  • Micahel Stratton
  • Ramaswamy Anbazhagan

There are no affiliations available

Personalised recommendations